LONDON, June 23 (Reuters) - The GAVI global vaccine alliance
has offered funding of up to $27.5 million for pilot tests of
GlaxoSmithKline's first-generation malaria vaccine, but
only if other organisations promise to match that commitment.
Read more
No comments:
Post a Comment